Value of tissue elastography in the prediction of efficacy of neoadjuvant chemotherapy in breast cancer

被引:5
|
作者
Fang, Chao [1 ]
Wu, Tingting [1 ]
Zhou, Yingying [1 ]
Xue, Jun [1 ]
Yang, Weiwei [1 ]
机构
[1] Zhabei Cent Hosp, 619 Zhonghua Xin Rd, Shanghai 200043, Peoples R China
来源
JOURNAL OF BUON | 2019年 / 24卷 / 02期
关键词
breast cancer; neoadjuvant chemotherapy; real-time tissue elastography; strain ratio; ULTRASOUND ELASTOGRAPHY; PATHOLOGICAL RESPONSE; SHEAR-WAVE; SYSTEM;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the present study was to explore the value of real-time tissue elastography (RTE) in predicting the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. Methods: A total of 60 patients with breast cancer who received NAC in our hospital were evaluated. According to the pathological results, 47 patients were included in the significant response group and 13 patients in the non-significant response group. The maximum diameter and strain ratio (B/A ratio) of lesions before and 1st, 2nd, 4th and 6th week after NAC were recorded and compared. The receiver operation characteristics (ROC) curve of the lesion diameter and strain rate ratio (B/A value) were used to predict the value of NAC efficacy. Results: The lesions in the two groups showed a honeycomb-like reduction after NAC. The blue color in the elastic image gradually decreased, and the green color gradually increased. Repeated analyses of variance (ANOVA) found that the maximum diameter and B/A value showed a downward trend within 6 weeks of NAC treatment. The maximum diameter and B/A value in the significant response group were significantly lower than the non-significant response group before and after the NAC. There was an interaction in the maximum diameter and B/A value between the significant response group and the non-significant response group. The above differences were statistically significant (all p <0.05). The area under the curve (AUC) of Delta B/A value at 2nd week of NAC was maximal (0.944), and the best diagnostic point was 5.64. The sensitivity was 92.31% and the specificity 87.23%. Conclusions: Delta B/A value at 2nd week of NAC is helpful in predicting the therapeutic effect of NAC in breast cancer.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [31] Value of FOXP3 expression in prediction of neoadjuvant chemotherapy effect in triple negative breast cancer
    Abdelazim, H.
    Loay, E.
    Ibrahim, B.
    El-Sheikh, S.
    VIRCHOWS ARCHIV, 2017, 471 : S56 - S56
  • [32] Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy
    Lee, Su Hyun
    Chang, Jung Min
    Han, Wonshik
    Moon, Hyeong-Gon
    Koo, Hye Ryoung
    Gweon, Hye Mi
    Kim, Won Hwa
    Noh, Dong-Young
    Moon, Woo Kyung
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S376 - S384
  • [33] Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy
    Su Hyun Lee
    Jung Min Chang
    Wonshik Han
    Hyeong-Gon Moon
    Hye Ryoung Koo
    Hye Mi Gweon
    Won Hwa Kim
    Dong-Young Noh
    Woo Kyung Moon
    Annals of Surgical Oncology, 2015, 22 : 376 - 384
  • [34] The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
    Mou, Daying
    Xie, Shengyan
    Li, Pingyuan
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [35] Neoadjuvant chemotherapy in breast cancer
    Charfare, H
    Limongelli, S
    Purushotham, AD
    BRITISH JOURNAL OF SURGERY, 2005, 92 (01) : 14 - 23
  • [36] Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI
    Evans, Andrew
    Whelehan, Patsy
    Thompson, Alastair
    Purdie, Colin
    Jordan, Lee
    Macaskill, Jane
    Waugh, Shelley
    Fuller-Pace, Frances
    Brauer, Katrin
    Vinnicombe, Sarah
    ULTRASCHALL IN DER MEDIZIN, 2018, 39 (04): : 422 - 431
  • [37] Neoadjuvant chemotherapy of breast cancer
    Garces, CA
    Cance, WG
    AMERICAN SURGEON, 2004, 70 (07) : 565 - 569
  • [38] Neoadjuvant chemotherapy in breast cancer
    Estévez L.G.
    Revista de Oncología, 2004, 6 (5): : 314 - 320
  • [39] Neoadjuvant chemotherapy for breast cancer
    Sapunar, F
    Smith, IE
    ANNALS OF MEDICINE, 2000, 32 (01) : 43 - 50